-
WHO grants emergency usage listing for Covaxin
Covaxin has demonstrated 77.8% effectiveness against symptomatic COVID-19 and 65.2% protection against the new Delta variant
-
Next challenge, make vaccines work against new variants: Adar Poonawalla
A lot of sacrifices were made to put the company's focus on Covishield
-
Indian students can travel to Australia as Covishield get approval down under
Australia had imposed very strict travel restrictions on people travelling in and out of the country
-
Apartheid in a different form
At a time when all countries need to be more inclusive to recover from the Covid-19 setback, the UK government’s move sends a worrying signal.
-
UK’s govt approves Covishield vaccine in its travel advisory
There is still no clarity on whether Indians who have been fully vaccinated with Covishield will require self-isolation on entering England
-
India administers 1.25 crore Covid vaccines daily: PM Modi
Modi also appreciated the tireless efforts of Covid warriors, including doctors, paramedical staff, Asha and anganwadi workers, and teachers
-
Pfizer and AstraZeneca less effective against Delta variant
Delta infections after two vaccine doses had similar peak levels of virus as those in unvaccinated people, the researchers said
-
Study on mixing of Covaxin and Covishield doses approved
An expert panel of the CDSCO, on July 29 had recommended granting permission for conducting the study. The trial will involve 300 healthy volunteers.
-
Covishield, Covaxin mixing can give better results: ICMR
A combination of Covishield followed by Covaxin was not only safe but also elicited better immunogenicity according to the ICMR's study.
-
Covishield dosage gap maybe reduced for 45+ age
India reported 44,643 new Covid-19 cases in the last 24 hours. With this, the active tally has climbed to 4,14,159
